Mei Brown

All read papers (41)

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1).

Lancet Neurol · 2013

2.5/5

Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position

Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ.

Nat Methods · 2013

4.0/5

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L.

Nature · 1991

4.0/5

Differential expression analysis for sequence count data

Anders S, Huber W.

Genome Biol · 2010

3.0/5

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, Frontera OA, De Marinis F, Turna H, Lee JS, Ballinger M, Kowanetz M, He P, Chen DS, Sandler A, Gandara DR, OAK Study Group.

Lancet · 2017

2.8/5

RNA targeting with CRISPR-Cas13

Abudayyeh OO, Gootenberg JS, Essletzbichler P, Han S, Joung J, Belanto JJ, Verdine V, Cox DBT, Kellner MJ, Regev A, Lander ES, Voytas DF, Ting AY, Zhang F.

Nature · 2017

3.5/5

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

Thorvaldsdóttir H, Robinson JT, Mesirov JP.

Brief Bioinform · 2013

2.5/5

Designing hydrogels for controlled drug delivery

Li J, Mooney DJ.

Nat Rev Mater · 2016

3.5/5

A comprehensive set of sequence analysis programs for the VAX

Devereux J, Haeberli P, Smithies O.

Nucleic Acids Res · 1984

2.8/5

RNA-Seq: a revolutionary tool for transcriptomics

Wang Z, Gerstein M, Snyder M.

Nat Rev Genet · 2009

3.3/5

StringTie enables improved reconstruction of a transcriptome from RNA-seq reads

Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL.

Nat Biotechnol · 2015

1.8/5

GSVA: gene set variation analysis for microarray and RNA-seq data

Hänzelmann S, Castelo R, Guinney J.

BMC Bioinformatics · 2013

1.5/5

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ.

Nat Biotechnol · 2011

3.0/5

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS.

Cancer Res · 2017

2.8/5

Circulating microRNAs as stable blood-based markers for cancer detection

Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M.

Proc Natl Acad Sci U S A · 2008

2.8/5

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD.

Proc Natl Acad Sci U S A · 1993

3.5/5

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Leng F, Edison P.

Nat Rev Neurol · 2021

4.0/5

Super-enhancers in the control of cell identity and disease

Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA, Young RA.

Cell · 2013

3.5/5

Neuroinflammation in Alzheimer's disease

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP.

Lancet Neurol · 2015

2.8/5

Adeno-associated virus vector as a platform for gene therapy delivery

Wang D, Tai PWL, Gao G.

Nat Rev Drug Discov · 2019

2.3/5

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE.

Nat Biotechnol · 2016

3.3/5

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A.

Cell · 2017

3.5/5

Metagenomic biomarker discovery and explanation

Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C.

Genome Biol · 2011

3.3/5

Cognitive reserve in ageing and Alzheimer's disease

Stern Y.

Lancet Neurol · 2012

3.0/5

Natural products in drug discovery: advances and opportunities

Atanasov AG, Zotchev SB, Dirsch VM, International Natural Product Sciences Taskforce, Supuran CT.

Nat Rev Drug Discov · 2021

1.8/5

Mechanisms underlying inflammation in neurodegeneration

Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH.

Cell · 2010

3.0/5

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Öhlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ, Chio II, Hwang CI, Tiriac H, Baker LA, Engle DD, Feig C, Kultti A, Egeblad M, Fearon DT, Crawford JM, Clevers H, Park Y, Tuveson DA.

J Exp Med · 2017

4.3/5

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, Heun R, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J.

Nat Genet · 2009

2.5/5

Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis

Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade M, Laneve P, Rajewsky N, Bozzoni I.

Mol Cell · 2017

2.8/5

DNA targeting specificity of RNA-guided Cas9 nucleases

Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F.

Nat Biotechnol · 2013

3.8/5

CRISPResso2 provides accurate and rapid genome editing sequence analysis

Clement K, Rees H, Canver MC, Gehrke JM, Farouni R, Hsu JY, Cole MA, Liu DR, Joung JK, Bauer DE, Pinello L.

Nat Biotechnol · 2019

3.0/5

Human MicroRNA targets

John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS.

PLoS Biol · 2004

3.3/5

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia.

Stroke · 2011

2.8/5

Post-transcriptional gene regulation by mRNA modifications

Zhao BS, Roundtree IA, He C.

Nat Rev Mol Cell Biol · 2017

2.5/5

A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae

Sikorski RS, Hieter P.

Genetics · 1989

4.3/5

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation

Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R.

J Neurosci · 2006

3.3/5

Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta

Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J.

Nature · 2000

3.8/5

A new coronavirus associated with human respiratory disease in China

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ.

Nature · 2020

3.5/5

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR.

Nature · 2016

2.3/5

Photodynamic therapy

Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q.

J Natl Cancer Inst · 1998

4.5/5

Pfam: The protein families database in 2021

Mistry J, Chuguransky S, Williams L, Qureshi M, Salazar GA, Sonnhammer ELL, Tosatto SCE, Paladin L, Raj S, Richardson LJ, Finn RD, Bateman A.

Nucleic Acids Res · 2021

2.8/5